This full-time Master's degree offers a thorough review of drug safety procedures used during the drug development process. It will provide you with cutting-edge training in preclinical toxicology, with a focus on the molecular in vitro and in vivo components of toxicology and safety pharmacology assessments. You will conduct an original research project as part of the programme, which will serve as the foundation for your dissertation. The curriculum, which is offered at the Institute of Cancer Therapeutics, a world-class research facility, equips you with the knowledge and abilities necessary for a job in the pharmaceutical business or regulatory organisations as well as the groundwork for a PhD.